Combo Monoclonal Antibody Drugs May Lower Coronavirus Loads

A recent study found the combination of bamlanivimab and etesevimab delivered early in the onset of SARS-CoV-2 disease resulted significantly lower viral loads at day 11 in patients than those who received a placebo. This effect was not seen in patients who were provided only one of the drugs.